<DOC>
	<DOCNO>NCT02582372</DOCNO>
	<brief_summary>Dexmedetomidine , highly selective agonist alpha-2 receptor , enhances sensory motor block prolong postoperative analgesia without hemodynamic compromise . OBJECTIVE : To evaluate effect dexmedetomidine v fentanyl hyperbaric bupivacaine spinal anesthesia lower abdominal surgery . METHODS : double-blind , randomize , American Society Anesthesiologist classification ( ASA ) : I - II , 18-65 year . F group ( 23 patient ) receive 25 mcg fentanyl , Group D ( 27 patient ) , 10 mcg dexmedetomidine 12.5 mg hyperbaric bupivacaine . 0,02mgrs morphine / kg intravenously EVAâ‰¥4was administer postoperative period . Hemodynamic variable O2 saturation intraoperatively record , EVA every 4 hour , side effect , sensory block , motor , sedation peripheral neurological manifestation toxicity .</brief_summary>
	<brief_title>Subarachnoidal Anesthesia : Dexmedetomidine v Fentanyl Plus Hyperbaric Bupivacaine Lower Abdomen Surgery</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>ASA I II low abdominal surgery Consumption antagonists adrenergic channel blocker Ca ++ Patients arrhythmias heart block Allergic drug study Obese Physical mental incapacity understand use pain scale Contraindication anesthesia conductive Realization difficulty complication anesthesia / surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>